Resources
BioMed Alliance Calls for Expert Involvement in EMA COI Policy
The BioMed Alliance recently responded to a public consultation regarding conflict of interest within the European Medicines Agency (EMA). The consultation published by the EMA follows a recent court...
BioMed Alliance replies to new consultation on HTA & cooperation with the EMA
In a new public consultation response, BioMed Alliance shares its views on the proposed implementing regulation detailing procedural rules for the cooperation of the Member State Coordination Group on...
2023 Report Highlights the importance of Life Science Investments in Europe
The report, "Attracting Life Science Investments in Europe," has been published in 2023 as an initiative by BioMed Alliance, EuropaBio, and Johnson & Johnson. The report consists of an analysis...
New statement advocates for a balanced approach to phasing out PFAS
In a new statement, BioMed Alliance provides insight on the harmful impacts of Per- and polyfluoroalkyl substances (PFAS) and urges manufacturers of medical devices to find safe alternatives whilst en...
New statement raises awareness on urgent deadline to avoid medical devices from disappearing
In a new statement, BioMed Alliance highlights its concerns regarding an imminent deadline in the Medical Devices Regulation (MDR), which will manufacturers have to meet to keep their devices on the m...
Statement raising awareness on urgent deadline to avoid medical devices from disappearing
In a new statement, BioMed Alliance highlights its concerns regarding an imminent deadline in the Medical Devices Regulation (MDR), which will manufacturers have to meet to keep their devices on the m...
Implementing EHDS: medical societies advise on how to bring health data sharing to the next level
In a new BioMed Alliance statement, medical societies provide key recommendations on the European Health Data Space (EHDS) implementation. The statement follows the European Parliaments adoption of th...
Statement on the implementation of the EHDS
In a new BioMed Alliance statement, medical societies provide key recommendations on the European Health Data Space (EHDS) implementation. The statement follows the European Parliaments adoption of th...
Charting the path forward: New joint stakeholder statement on the implementation of the EHDS
BioMed Alliance contributed to a new statement on the implementation of the European Health Data Space signed by 36 organisations representing healthcare professionals, patients, industry and other he...
BioMed Alliance replies to consultation on HTA Implementing Regulation
BioMed Alliance replied to the public consultation on the HTA Implementing Regulation on joint clinical assessments of medicinal products. In the reply, BioMed Alliance argues that the involvement of...
New multistakeholder statement on EHDS
The BioMed Alliance has contributed to a joint statement issued by a large multistakeholder group, representing the entire spectrum of the healthcare ecosystem and consisting of 35 European patient or...
Multistakeholder statement on EHDS
The BioMed Alliance has contributed to a joint statement issued on 26 February 2024 by a large multistakeholder group, representing the entire spectrum of the healthcare ecosystem and consisting of 35...